אודות פרק זה
In part 1 of our two-part series, “FROM CLINICAL TRIALS TO COMMERCIALIZATION: THE PHARMA-HEALTHCARE GLOBAL SUPPLY CHAIN,” we discussed what’s required to maintain a successful global supply chain—one that can include life-changing and life-saving shipments.
In this episode of QuickConversations we’re joined by a guest podcaster from our parent company, Kuehne+Nagel: Robert Coyle, Senior Vice President of Pharma & Healthcare Strategy. Also joining us again is QuickSTAT’s Scott Ohanesian, Senior Vice President Operations, Clinical Trial Logistics. Together they represent the end-to-end planning and execution of the pharma product life cycle process.
Now, in part 2 – “COMMUNICATIONS, EXPECTATIONS & HIDDEN HEROES” – we dig deeper into supply chain planning and strategy, specifically the critical role that clear, frequent communications plays. We’ll also hear what it takes to move urgent, life-critical cell & gene therapies to and from patients – as well as to help manage some of the most important clinical drug trials of our time.
One Quick ask before we begin this second of our two-part series with Rob and Scott. If this podcast inspires a question for Rob or Scott, please reach out to them! Go to quick.aero/podcasts and click on the “Ask The Podcasters” link. And if you’d like a transcript of the conversation, you also can download a copy on this page as well. Or visit Kuehne+Nagel’s website at kuehne-nagel.com and search for “podcasts.”
